Neal Walker, President and CEO at Aclaris Therapeutics, Inc. (ACRS), sold 112,606 shares at $15.91 ($1.8M) on 2022-03-11, disclosed to the SEC on 2022-03-14.
Open-market sale of $1.8M ACRS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.91 | 56,303 | $896K | 50.0% |
| 2 | $15.91 | 56,303 | $896K | 50.0% |
| Total | $15.91 avg | 112,606 | $1.8M | 100% |
| Filing → |
| ACRS | SELL | 2023-01-04 | $960K | — | Filing → |
| ACRS | SELL | 2022-04-25 | $1.1M | — | Filing → |
| ACRS | SELL | 2022-02-11 | $46K | — | Filing → |